Benzinga's Top #PreMarket Losers
Celldex Therapeutics (NASDAQ: CLDX) dipped 9.47% to $25.63 in the pre-market session after the company reported positive Phase 2 rindopepimut data in patients with recurrent glioblastoma.
J. C. Penney Company (NYSE: JCP) dipped 2.59% to $8.64. J.C. Penney will leave the Standard & Poor's 500 index. The retailer will be replaced by Allegion Plc in the index.
JetBlue Airways (NASDAQ: JBLU) shares dropped 2.09% to $8.90 in pre-market trading after Raymond James downgraded the stock from Market Perform to Underperform.
Qiagen NV (NASDAQ: QGEN) shares fell 1.61% to $23.18 in the pre-market trading. Qiagen's PEG ratio is 3.34.
© 2014 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.